Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Longwood Biopharmaceuticals divulges PD-1/PD-L1 interaction inhibitors

Nov. 30, 2021

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Eli Lilly divulges new MRGPRX1 agonists

Nov. 29, 2021

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Nov. 26, 2021

Merck, Cancer Research Technology divulge YAP1/TEAD interaction inhibitors

Nov. 26, 2021

Takeda Pharmaceutical presents new ABCC2 inhibitors

Nov. 26, 2021

New MAP4K1 inhibitors synthesized at Pfizer

Nov. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...